Related references
Note: Only part of the references are listed.Therapeutic RNA interference targeting CKIP-1 with a cross-species sequence to stimulate bone formation
Baosheng Guo et al.
BONE (2014)
Developing aptamer probes for acute myelogenous leukemia detection and surface protein biomarker discovery
Mingli Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
miR-214 targets ATF4 to inhibit bone formation
Xiaogang Wang et al.
NATURE MEDICINE (2013)
Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles
Barbara L. Mui et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Advances in Lipid Nanoparticles for siRNA Delivery
Yuen Tam et al.
Pharmaceutics (2013)
RNA therapeutics targeting osteoclast-mediated excessive bone resorption
Yuwei Wang et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Generating Aptamers by Cell-SELEX for Applications in Molecular Medicine
Mao Ye et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy
Ge Zhang et al.
NATURE MEDICINE (2012)
Macropinocytosis: an endocytic pathway for internalising large gulps
Jet Phey Lim et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Rational Truncation of an RNA Aptamer to Prostate-Specific Membrane Antigen Using Computational Structural Modeling
William M. Rockey et al.
NUCLEIC ACID THERAPEUTICS (2011)
Isolation and characterization of a novel peptide, osteoblast activating peptide (OBAP), associated with osteoblast differentiation and bone formation
Nobuhiro Fukushima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration
Guilin Wang et al.
JOURNAL OF DRUG TARGETING (2010)
The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and Pitfalls
Dries Vercauteren et al.
MOLECULAR THERAPY (2010)
Rational design of cationic lipids for siRNA delivery
Sean C. Semple et al.
NATURE BIOTECHNOLOGY (2010)
Development of DNA aptamers using Cell-SELEX
Kwame Sefah et al.
NATURE PROTOCOLS (2010)
Aptamers as therapeutics
Anthony D. Keefe et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
RNA Interference Technologies and Therapeutics From Basic Research to Products
Marta Lopez-Fraga et al.
BIODRUGS (2009)
Pentosidine effects on human osteoblasts in vitro
Roberta Sanguineti et al.
MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES (2008)
Induction of Osteoclast-Associated Receptor, a Key Osteoclast Costimulation Molecule, in Rheumatoid Arthritis
Sonja Herman et al.
ARTHRITIS AND RHEUMATISM (2008)
Triggered release of siRNA from poly(ethylene glycol)-protected, pH-dependent liposomes
Debra T. Auguste et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Pharmacokinetics and biodistribution of nanoparticles
Shyh-Dar Li et al.
MOLECULAR PHARMACEUTICS (2008)
Targeting WW domains linker of HECT-type ubiquitin ligase Smurf1 for activation by CKIP-1
Kefeng Lu et al.
NATURE CELL BIOLOGY (2008)
First-in-human evaluation of anti-von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers
James C. Gilbert et al.
CIRCULATION (2007)
Nonviral delivery of synthetic siRNAs in vivo
Saghir Akhtar et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Dynamin 2 mediates fluid-phase micropinocytosis in epithelial cells
Hong Cao et al.
JOURNAL OF CELL SCIENCE (2007)
Changes of microstructure and mineralized tissue in the middle and late phase of osteoporotic fracture healing in rats
Yingjie Hao et al.
BONE (2007)
Bone-targeting macromolecular therapeutics
D Wang et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Gene expression relevant to osteoclastogenesis in the synovium and bone marrow of mature rats with collagen-induced arthritis
Y Kishimoto et al.
RHEUMATOLOGY (2004)
Involvement of FcRγ in signal transduction of osteoclast-associated receptor (OSCAR)
S Ishikawa et al.
INTERNATIONAL IMMUNOLOGY (2004)
Share Paper
